Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
Add more filters











Publication year range
1.
In. CASMU. Investigación clínica: desarrollo e innovación, 2019. Montevideo, Ideas Uruguay, 2019. p.93-100.
Monography in Spanish | LILACS, UY-BNMED, BNUY | ID: biblio-1359503
2.
Biometals ; 30(5): 663-675, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28733845

ABSTRACT

Trace elements such as Zinc and Iron are essential components of metalloproteins and serve as cofactors or structural elements for enzymes involved in several important biological processes in almost all organisms. Because either excess or insufficient levels of Zn and Fe can be harmful for the cells, the homeostatic levels of these trace minerals must be tightly regulated. The Zinc regulated transporter, Iron regulated transporter-like Proteins (ZIP) comprise a diverse family, with several paralogues in diverse organisms and are considered essential for the Zn and Fe uptake and homeostasis. Zn and Fe has been shown to regulate expression of proteins involved in metabolism and pathogenicity mechanisms in the protozoan pathogen Trichomonas vaginalis, in contrast high concentrations of these elements were also found to be toxic for T. vaginalis trophozoites. Nevertheless, Zn and Fe uptake and homeostasis mechanisms is not yet clear in this parasite. We performed a genome-wide analysis and localized the 8 members of the ZIP gene family in T. vaginalis (TvZIP1-8). The bioinformatic programs predicted that the TvZIP proteins are highly conserved and show similar properties to the reported in other ZIP orthologues. The expression patterns of TvZIP1, 3, 5 and 7 were diminished in presence of Zinc, while the rest of the TvZIP genes showed an unchanged profile in this condition. In addition, TvZIP2 and TvZIP4 showed a differential expression pattern in trophozoites growth under different Iron conditions. These results suggest that TvZIP genes encode membrane transporters that may be responsible for the Zn and Fe acquisition in T. vaginalis.


Subject(s)
Cation Transport Proteins/genetics , Genome, Protozoan , Iron/metabolism , Protozoan Proteins/genetics , Trichomonas vaginalis/genetics , Zinc/metabolism , Amino Acid Sequence , Arabidopsis , Cation Transport Proteins/metabolism , Computational Biology , Ferrous Compounds/pharmacology , Gene Expression Regulation , Homeostasis , Ion Transport , Protein Isoforms/genetics , Protein Isoforms/metabolism , Protozoan Proteins/metabolism , Saccharomyces cerevisiae , Sequence Alignment , Sequence Homology, Amino Acid , Trichomonas vaginalis/drug effects , Trichomonas vaginalis/metabolism , Zinc Sulfate/pharmacology
3.
J Obstet Gynaecol ; 30(1): 49-52, 2010 Jan.
Article in English | MEDLINE | ID: mdl-20121505

ABSTRACT

We prospectively collected data on all patients with stage IB1 cervical cancer, who underwent total laparoscopic radical hysterectomy with the use of a modified uterine manipulator. From January 2000 to December 2005, 54 patients met the study criteria. The mean age was 41.8 +/- 7.47 years. Average BMI (kg/m(2)) was 27.38 +/- 3.13. Squamous carcinoma and adenocarcinoma were found in 88.88% and 11.11% of the cases, respectively. The average surgical time was 265 +/- 70.8 min. The mean estimated blood loss was 276.11 +/- 123.03 ml. The average patient lymph node count was 19.64 +/- 5.08. Positive malignant lymph nodes were identified in 11.11% of the cases. Surgical margins were free of disease in all patients. The mean hospital stay was 1.5 +/- 1 days. There was no mortality. Total laparoscopic radical hysterectomy can be considered a safe alternative to laparotomy. The use of a uterine manipulator does not pose an increased surgical risk and allows for a simpler and more feasible procedure.


Subject(s)
Adenocarcinoma/surgery , Carcinoma, Squamous Cell/surgery , Hysterectomy, Vaginal/instrumentation , Laparoscopy/methods , Uterine Cervical Neoplasms/surgery , Adult , Female , Humans , Hysterectomy, Vaginal/methods , Middle Aged , Prospective Studies
4.
Infect Genet Evol ; 9(6): 1065-74, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19539055

ABSTRACT

Trichomonas vaginalis has high iron-dependency, favoring its growth and multiplication in culture. Iron also regulates some of the trichomonal virulence properties by yet unknown mechanisms. Iron is an essential but potentially toxic metal for the majority of organisms. Thus, its concentration must be tightly regulated within the cell. In mammals, the iron homeostasis is mainly regulated at the post-transcriptional level by a well known mechanism mediated by the binding of iron regulatory proteins (IRP1 and IRP2) to hairpin-loop structures, dubbed iron-responsive elements (IREs), localized in the untranslated regions (UTRs) of target mRNAs. The knowledge of iron regulation in T. vaginalis is still very limited. An iron-responsive promoter and other regulatory elements in the 5'-UTR of the ap65-1 gene were identified as a mechanism for the positive transcriptional regulation of trichomonad genes by iron. Recently, two IRE-like hairpin-loop structures in mRNAs of differentially iron-regulated TVCP4 and TVCP12 cysteine proteinases, as well as IRP-like trichomonad proteins were identified in T. vaginalis, suggesting the existence in this protozoan of a post-transcriptional iron regulatory mechanism by an IRE/IRP-like system. The responsiveness of T. vaginalis to distinct iron concentrations was examined here. Also, the comparison of the atypical IRE-like sequences of T. vaginalis with the consensus IRE and other putative IRE sequences present in parasite and bacteria mRNAs suggest that these trichomonad IRE-like sequences might be the ancestral forms of the RNA stem-loop structures of the IRE/IRP system.


Subject(s)
Homeostasis , Iron-Regulatory Proteins/metabolism , Iron/metabolism , Transcription, Genetic , Trichomonas vaginalis/physiology , Animals , Base Sequence , Cell Adhesion Molecules/genetics , Cell Adhesion Molecules/metabolism , Cysteine Proteases/genetics , Cysteine Proteases/metabolism , DNA, Protozoan/analysis , DNA, Protozoan/genetics , Female , Gene Expression Regulation , Genome, Protozoan , Humans , Iron/chemistry , Iron-Regulatory Proteins/genetics , Molecular Sequence Data , Protozoan Proteins/genetics , Protozoan Proteins/metabolism , Trichomonas Vaginitis/metabolism , Trichomonas Vaginitis/parasitology , Trichomonas vaginalis/chemistry , Trichomonas vaginalis/pathogenicity , Virulence
5.
Braz J Med Biol Res ; 41(2): 170-5, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18297197

ABSTRACT

This study was undertaken in anesthetized dogs to evaluate the relative participation of prostaglandins (PGs) and nitric oxide (NO) in the maintenance of total renal blood flow (TRBF), and renal medullary blood flow (RMBF). It was hypothesized that the inhibition of NO should impair cortical and medullary circulation because of the synthesis of this compound in the endothelial cells of these two territories. In contrast, under normal conditions of perfusion pressure PG synthesis is confined to the renal medulla. Hence PG inhibition should predominantly impair the medullary circulation. The initial administration of 25 microM kg-1 min-1 NG-nitro-L-arginine methyl ester produced a significant 26% decrease in TRBF and a concomitant 34% fall in RMBF, while the subsequent inhibition of PGs with 5 mg/kg meclofenamate further reduced TRBF by 33% and RMBF by 89%. In contrast, the initial administration of meclofenamate failed to change TRBF, while decreasing RMBF by 49%. The subsequent blockade of NO decreased TRBF by 35% without further altering RMBF. These results indicate that initial PG synthesis inhibition predominantly alters the medullary circulation, whereas NO inhibition decreases both cortical and medullary flow. This latter change induced by NO renders cortical and RMBF susceptible to a further decrease by PG inhibition. However, the decrease in medullary circulation produced by NO inhibition is not further enhanced by subsequent PG inhibition.


Subject(s)
Kidney Cortex/blood supply , Kidney Medulla/blood supply , Nitric Oxide/physiology , Prostaglandins/physiology , Animals , Bradykinin/pharmacology , Cyclooxygenase Inhibitors/pharmacology , Dogs , Kidney Cortex/drug effects , Kidney Medulla/drug effects , Male , Meclofenamic Acid/pharmacology , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide/antagonists & inhibitors , Prostaglandin Antagonists/pharmacology , Regional Blood Flow/drug effects , Vasodilator Agents/pharmacology
6.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;41(2): 170-175, Feb. 2008. graf
Article in English | LILACS | ID: lil-474759

ABSTRACT

This study was undertaken in anesthetized dogs to evaluate the relative participation of prostaglandins (PGs) and nitric oxide (NO) in the maintenance of total renal blood flow (TRBF), and renal medullary blood flow (RMBF). It was hypothesized that the inhibition of NO should impair cortical and medullary circulation because of the synthesis of this compound in the endothelial cells of these two territories. In contrast, under normal conditions of perfusion pressure PG synthesis is confined to the renal medulla. Hence PG inhibition should predominantly impair the medullary circulation. The initial administration of 25 µM kg-1 min-1 NG-nitro-L-arginine methyl ester produced a significant 26 percent decrease in TRBF and a concomitant 34 percent fall in RMBF, while the subsequent inhibition of PGs with 5 mg/kg meclofenamate further reduced TRBF by 33 percent and RMBF by 89 percent. In contrast, the initial administration of meclofenamate failed to change TRBF, while decreasing RMBF by 49 percent. The subsequent blockade of NO decreased TRBF by 35 percent without further altering RMBF. These results indicate that initial PG synthesis inhibition predominantly alters the medullary circulation, whereas NO inhibition decreases both cortical and medullary flow. This latter change induced by NO renders cortical and RMBF susceptible to a further decrease by PG inhibition. However, the decrease in medullary circulation produced by NO inhibition is not further enhanced by subsequent PG inhibition.


Subject(s)
Animals , Dogs , Male , Kidney Cortex/blood supply , Kidney Medulla/blood supply , Nitric Oxide/physiology , Prostaglandins/physiology , Bradykinin/pharmacology , Cyclooxygenase Inhibitors/pharmacology , Kidney Cortex/drug effects , Kidney Medulla/drug effects , Meclofenamic Acid/pharmacology , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide/antagonists & inhibitors , Prostaglandin Antagonists/pharmacology , Regional Blood Flow/drug effects , Vasodilator Agents/pharmacology
7.
Braz J Med Biol Res ; 33(6): 653-60, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10829093

ABSTRACT

It is well known that essential hypertension evolves in most patients with "near normal" levels of plasma renin activity. However, these levels appear to be responsible for the high levels of arterial pressure because they are normalized by the administration of angiotensin II converting inhibitors or angiotensin receptor antagonist. In experimental animals, hypertension can be induced by the continuous intravenous infusion of small doses of angiotensin II that are not sufficient to evoke an immediate pressor response. However, this condition resembles the characteristics of essential hypertension because the high levels of blood pressure exist with normal plasma levels of angiotensin II. It is suggested that small amounts of angiotensin whose plasma levels are inappropriate for the existing size of extracellular volume stimulate oxidative stress which binds nitric oxide forming peroxynitrite. The latter compound oxidizes arachidonic acid producing isoprostaglandin F2alpha (an isoprostane) which is characterized by a strong antinatriuretic vasoconstrictor renal effect. In this chain of reactions the vasoconstrictor effects derived from oxygen quenching of nitric oxide and increased isoprostane synthesis could explain how hypertension is maintained with normal plasma levels of renin.


Subject(s)
Angiotensin II/physiology , Hypertension/physiopathology , Oxidative Stress/physiology , Angiotensin II/blood , Animals , Endothelins/physiology , Extracellular Space , Hypertension/blood , Nitric Oxide/physiology , Receptors, Prostaglandin/physiology , Renin/blood , Renin/metabolism , Sodium Chloride/pharmacology , Swine
8.
Am J Kidney Dis ; 33(1): 43-51, 1999 Jan.
Article in English | MEDLINE | ID: mdl-9915266

ABSTRACT

In congestive heart failure (CHF), the neurohormonal mechanisms that cause renal vasoconstriction, particularly those depending on the renin-angiotensin system, could interfere with renal vasodilating mechanisms. To elucidate this issue, we studied the kidney response to an amino acid infusion (known to cause renal vasodilation in healthy individuals) in eight patients with CHF. We found that the amino acid infusion (0.7 mL/kg/h of a 10% solution) elicited no renal hemodynamic response, in marked contrast to healthy subjects. We next hypothesized that the renin-angiotensin system (known to be activated in heart failure) has a role in the lack of response to the amino acid infusion. To test this hypothesis, we repeated the study after two 5-mg doses of enalapril, an inhibitor of the angiotensin-converting enzyme, administered 12 hours apart. After enalapril treatment, the amino acid infusion caused a 45% increase in mean renal blood flow (RBF) from 383 +/- 55 to 557 +/- 51 mL/min at the fifth hour (P < 0.05). This normalization of the renal response to the amino acid infusion occurred without changes in cardiac output or in systemic vascular resistance. Hence, the renal fraction of the cardiac output increased during the amino acid infusion. The recovery of the renal vascular response was not accompanied by an increase in glomerular filtration rate (GFR; filtration fraction decreased), suggesting a predominant efferent arteriole dilatation. Our study shows that, in heart failure, the kidney loses its ability to increase RBF in response to an amino acid load. This lack of renal vascular response can be restored by inhibiting the renin-angiotensin system and is unrelated to changes in systemic hemodynamics.


Subject(s)
Amino Acids/administration & dosage , Angiotensin-Converting Enzyme Inhibitors/administration & dosage , Enalapril/administration & dosage , Heart Failure/physiopathology , Renal Artery/drug effects , Vasodilation/drug effects , Aged , Analysis of Variance , Female , Heart Failure/metabolism , Hemodynamics/drug effects , Hemodynamics/physiology , Humans , Infusions, Intravenous , Male , Middle Aged , Renal Artery/physiopathology , Renin-Angiotensin System/drug effects , Renin-Angiotensin System/physiology , Time Factors , Vasodilation/physiology
9.
Hypertension ; 23(1 Suppl): I225-30, 1994 Jan.
Article in English | MEDLINE | ID: mdl-8282364

ABSTRACT

In the present study, we evaluated the renal response to a 4-hour infusion of amino acids in essential hypertensive patients, as well as the effects that dietary sodium restriction and enalapril (a converting enzyme inhibitor) had on this renal response. During normal sodium intake, amino acid infusion significantly increased renal plasma flow from 383 +/- 58 to 478 +/- 51 mL/min and glomerular filtration rate from 82 +/- 8 to 100 +/- 13 mL/min. All these effects were abolished when the patients received a low sodium diet (40 mmol/d) for 3 days before the amino acid infusion. The administration of enalapril to the patients during sodium restriction restored the amino acid-induced increment in renal plasma flow (from 388 +/- 35 to 573 +/- 48 mL/min) and glomerular filtration rate (from 88 +/- 9 to 103 +/- 10 mL/min). Mean arterial pressure remained unaltered under all experimental conditions. The results show that in patients with essential hypertension dietary sodium restriction prevents amino acid-induced increments in glomerular filtration rate and renal plasma flow and that this effect is restored during the simultaneous administration of enalapril.


Subject(s)
Amino Acids/pharmacology , Blood Pressure/drug effects , Enalapril/pharmacology , Hypertension/physiopathology , Kidney/drug effects , Adult , Aged , Aldosterone/blood , Amino Acids/administration & dosage , Angiotensin II/blood , Diastole/drug effects , Diet, Sodium-Restricted , Female , Glomerular Filtration Rate/drug effects , Humans , Hypertension/diet therapy , Infusions, Intravenous , Kidney/blood supply , Kidney/physiopathology , Male , Middle Aged , Regional Blood Flow/drug effects , Renin/blood , Sodium/urine , Systole/drug effects , Urine
10.
Hypertension ; 15(3): 257-61, 1990 Mar.
Article in English | MEDLINE | ID: mdl-2137431

ABSTRACT

Renal functional reserve, microalbuminuria, and plasma atrial natriuretic factor were measured in 21 offspring (9.5 +/- 0.5 years of age, mean +/- SEM) of hypertensive parents and in eight children (10 +/- 0.5 years of age) with no family history of hypertension who were used as a control group. Renal functional reserve was evaluated by measurement of the changes in creatinine clearance after an oral protein load of 45 g/m2. Atrial natriuretic factor levels were determined before and 60 minutes after the protein load, and microalbuminuria in fractional urine before and 120 minutes after the same stimulus as well as in a 24-hour urine collection. All children in the control group significantly increased their creatinine clearance after the protein load (preload, 122 +/- 12; 60 minutes, 144 +/- 9; 120 minutes, 154 +/- 11; 180 minutes, 144 +/- 9 ml/min/1.73 m2; all values were significant vs. preload, p less than 0.005). In contrast, only 13 of 21 offspring of hypertensive parents increased their creatinine clearance to values within 2 SD of the increase shown by the control group (preload, 144 +/- 11; 60 minutes, 153 +/- 7; 120 minutes, 202 +/- 13 ml/min/1.73 m2; p less than 0.001 vs. preload; 180 minutes, 214 +/- 19 ml/min/1.73 m2, p less than 0.001 vs. preload). The remaining eight offspring of hypertensive parents showed no detectable changes (nonresponders) (preload, 189 +/- 18; 60 minutes, 146 +/- 11; 120 minutes, 170 +/- 14; 180 minutes, 168 +/- 13 ml/min/1.73 m2; all values p = NS). No changes in atrial natriuretic factor after the protein load were observed in any group. Offspring of hypertensive parents presented higher microalbuminuria levels in 24-hour urine specimens (3.1 micrograms/min, tolerance factor [TF]2.2) than controls (2.1 micrograms/min, TF 1.5) (p less than 0.05). Although microalbuminuria increased significantly after the water load in the control group (p less than 0.05) and in the offspring of hypertensive parents (p less than 0.01), it returned to baseline at 120 minutes in the former but not in the latter (p less than 0.05 vs. baseline). The lack of renal functional reserve in nonresponders was significantly related (p less than 0.05) to the presence of higher levels of microalbuminuria. We conclude that the absence of renal functional reserve and increased microalbuminuria in some normotensive children who are offspring of essential hypertensive parents can indicate that subtle alterations in renal function may precede the onset of clinical hypertension.


Subject(s)
Albuminuria/metabolism , Hypertension/physiopathology , Adolescent , Atrial Natriuretic Factor/pharmacology , Child , Child, Preschool , Female , Glomerular Filtration Rate , Humans , Hypertension/metabolism , Kidney/physiology , Male
16.
SELECTION OF CITATIONS
SEARCH DETAIL